Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Berman

Showing results (91-100 of 111) with videos related to

Pageof 12
Sort By:
Nature Communications|June 4, 2026
Methylation-based ctDNA monitoring in metastatic breast cancer during CDK4/6 inhibitor therapyMitchell J Elliott, Jesús Fuentes-Antrás, Sasha C Main, et al.
Cancer Discovery|July 11, 2012
CD36 repression activates a multicellular stromal program shared by high mammographic density and tumor tissuesRosa Anna DeFilippis, Hang Chang, Nancy Dumont, et al.
Breast Cancer Research and Treatment|November 28, 2017
Impact of multi-gene mutational profiling on clinical trial outcomes in metastatic breast cancerRossanna C Pezo, Tom W Chen, Hal K Berman, et al.
Nature Communications|February 21, 2025
Longitudinal evaluation of circulating tumor DNA in patients undergoing neoadjuvant therapy for early breast cancer using a tumor-informed assayMitchell J Elliott, Philippe Echelard, Christodoulos Pipinikas, et al.
NPJ Precision Oncology|June 3, 2026
Longitudinal evaluation of serial ctDNA kinetics using joint modeling in patients with metastatic breast cancerChristopher Pretz, Jesús Fuentes-Antrás, Sasha Main, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2007
Stratification of breast cancer risk in women with atypia: a Mayo cohort studyAmy C Degnim, Daniel W Visscher, Hal K Berman, et al.
Cancer Immunology Research|December 21, 2014
B7-H4 expression by nonhematopoietic cells in the tumor microenvironment promotes antitumor immunityRamtin Rahbar, Albert Lin, Magar Ghazarian, et al.
JCO Precision Oncology|February 9, 2022
Minimally Invasive Real-Time Detection of Actionable Mutations in Patients With Metastatic Solid Tumors Using Fine-Needle and Liquid BiopsiesKyaw L Aung, Philippe L Bedard, Celeste Yu, et al.
The Journal of Experimental Medicine|July 17, 2013
BRCA1 interacts with Nrf2 to regulate antioxidant signaling and cell survivalChiara Gorrini, Pegah S Baniasadi, Isaac S Harris, et al.
Nature Medicine|February 7, 2017
A distinct innate lymphoid cell population regulates tumor-associated T cellsSarah Q Crome, Linh T Nguyen, Sandra Lopez-Verges, et al.
Pageof 12

Showing results (91-100 of 111) with videos related to

Sort By:
Pageof 12
Nature Communications|June 4, 2026
Methylation-based ctDNA monitoring in metastatic breast cancer during CDK4/6 inhibitor therapyMitchell J Elliott, Jesús Fuentes-Antrás, Sasha C Main, et al.
Cancer Discovery|July 11, 2012
CD36 repression activates a multicellular stromal program shared by high mammographic density and tumor tissuesRosa Anna DeFilippis, Hang Chang, Nancy Dumont, et al.
Breast Cancer Research and Treatment|November 28, 2017
Impact of multi-gene mutational profiling on clinical trial outcomes in metastatic breast cancerRossanna C Pezo, Tom W Chen, Hal K Berman, et al.
Nature Communications|February 21, 2025
Longitudinal evaluation of circulating tumor DNA in patients undergoing neoadjuvant therapy for early breast cancer using a tumor-informed assayMitchell J Elliott, Philippe Echelard, Christodoulos Pipinikas, et al.
NPJ Precision Oncology|June 3, 2026
Longitudinal evaluation of serial ctDNA kinetics using joint modeling in patients with metastatic breast cancerChristopher Pretz, Jesús Fuentes-Antrás, Sasha Main, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2007
Stratification of breast cancer risk in women with atypia: a Mayo cohort studyAmy C Degnim, Daniel W Visscher, Hal K Berman, et al.
Cancer Immunology Research|December 21, 2014
B7-H4 expression by nonhematopoietic cells in the tumor microenvironment promotes antitumor immunityRamtin Rahbar, Albert Lin, Magar Ghazarian, et al.
JCO Precision Oncology|February 9, 2022
Minimally Invasive Real-Time Detection of Actionable Mutations in Patients With Metastatic Solid Tumors Using Fine-Needle and Liquid BiopsiesKyaw L Aung, Philippe L Bedard, Celeste Yu, et al.
The Journal of Experimental Medicine|July 17, 2013
BRCA1 interacts with Nrf2 to regulate antioxidant signaling and cell survivalChiara Gorrini, Pegah S Baniasadi, Isaac S Harris, et al.
Nature Medicine|February 7, 2017
A distinct innate lymphoid cell population regulates tumor-associated T cellsSarah Q Crome, Linh T Nguyen, Sandra Lopez-Verges, et al.
Pageof 12